Hide Board Information

Show Board Information

Fabled Silver Gold Corp. FBSGF

Board Mod: Add me as mod

Asst Mods:

Last Post: 03/28/2023 5:34:39 AM

Board Marks: 0

Posts Today: 0

Board Views Today: 9

Fabled Silver Gold Corp. (OTCMRKTS: FBSGF) Stock Message Board

1. FBSGF Company Profile

    

2. FBSGF Time & Sales

    

3. FBSGF Recent News

    

4. FBSGF Filings

    

5. FBSGF Financials

    

6. FBSGF Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

Be the first to post on Fabled Silver Gold Corp. FBSGF

Recent Articles

• DHT Holdings Responds to Recent Shipping Fee Announcement
• Leadership Changes at La-Z-Boy to Drive Future Innovations
• Par Pacific Prepares for Q3 2025 Earnings and Call Update
• DHT Holdings, Inc. Welcomes Svein Moxnes Harfjeld to Its Board
• Unlocking the Potential of Teledyne Technologies Investment
• Polaris Divests Indian Motorcycle to Carolwood for Growth
• Mullins McLeod Leads with Strong Fundraising Momentum in SC
• Weekly Share Trading Update for Banijay Group Holdings
• Zentalis Pharmaceuticals Highlights Azenosertib at Major Cancer Conference
• NexusTek Achieves 2025 Triple Crown for Outstanding Performance
• PHH Mortgage Unveils Innovative FlexIQ Non-QM Product Suite
• iMDx Targets Transplant Market with New VP Marketing Appointment
• Par Pacific Holdings Prepares for Upcoming Earnings Call
• SM Energy Announces Upcoming Earnings Call and Q3 Results Release
• FTAI Aviation and Finnair Forge Partnership for Engine Solutions
• Explore Pyxis Oncology's Innovative Approach to Cancer Treatment
• Select Water Solutions Prepares for Upcoming Earnings Call
• Talos Energy's Upcoming Earnings Call and Q3 Results Release
• DHT Holdings Welcomes Svein Moxnes Harfjeld to Board
• Casella Waste Systems Plans Conference Call for Quarter Results
• NMI Holdings Prepares for Upcoming Financial Results Announcement
• Boundless Bio to Present Breakthrough Cancer Research at AACR
• MAIA Biotechnology Secures $736,600 in New Funding for Trials
• LifeVantage to Showcase Innovations at Upcoming LD Micro Event
• PMV Pharmaceuticals Showcases Rezatapopt Insights at Conference
• Spyre Therapeutics Unveils Exciting Stock Offering Details
• BBOT Showcases Innovative Cancer Therapeutics at Key Conference
• Bombardier Global 8000: The New Era of Speed in Business Aviation
• James River Group's Upcoming Third Quarter Earnings Call Details
• Adeia Inc. Ready to Share Q3 2025 Financial Insights Soon
• iMDx Appoints Steven Tahmooressi as New Marketing VP
• Upcoming Earnings Call for The RealReal: What to Expect
• Insights into BBOT's Upcoming Presentations at AACR-NCI-EORTC
• PubMatic Inc. Investors: Important Class Action Update
• Discover the Latest Advancements from Zentalis Pharmaceuticals
• Unraveling the Mechanism of Action of MICVO in Cancer Therapy
• QuantumScape Stock Soars: New Opportunities in Battery Tech
• LifeVantage to Showcase Innovative Health Products at LD Micro Event
• EverQuote Set to Present Q3 2025 Financial Results Soon
• New Developments at Boundless Bio Spark Excitement in Oncology
• Investors Urged to Act Fast on Quantum Corporation Class Action
• Avadel Pharmaceuticals Reports Employee Stock Options Grant
• Hubbell Set to Reveal Q3 Financial Insights on October 28
• Investors Advised on Jasper Therapeutics Class Action Options
• Casella Waste Systems Reveals Conference Call for Results
• Rocky Mountain Chocolate Factory Builds Momentum in 2026
• Understanding Core & Main: P/E Ratio Insights for Investors
• KLA Corporation's Options Trends and Market Analysis Explained
• James River Group Earnings Call Announcement for Investors
• Salesforce Options Trading Insights: Understanding Market Dynamics